The concept of time toxicity: A patient's perspective

Interpreting statistics in clinical trials

Choosing the control arm/standard of care in clinical trials

Building collaborations for cancer research

Defining Value in Indian healthcare: Asking the right questions

Sustainability in delivering healthcare - The Gordon McVie Lecture

Cancer survivors' stories: An African perspective

ESMO 2022: Breast and ovarian trial analysis

ERMES study suggests a strategy of de-escalation with only cetuximab in first line therapy for RAS and BRAF wild type mCRC

Neoadjuvant immunotherapy improves outlook in high-risk melanoma

Potential for enfortumab vedotin plus pembrolizumab in cisplatin-ineligible locally advanced or metastatic urothelial cancer

Pembrolizumab/carboplatin/paclitaxel combo shows antitumour activity in first-line recurrent/metastatic HNSCC